Prognostic significance of membrane antigens and morphology in chronic lymphocytic leukemia.

Prognostic significance of membrane antigens and morphology in chronic lymphocytic leukemia.

Dettagli Bibliografici
Autori principali:	Matutes, E, Halsey, J, Morilla, R, Atkinson, S, Marco, J, Richards, S, Catovsky, D, Party, M
Natura:	Journal article
Pubblicazione:	1999

Documenti analoghi

The clinical significance of patients' sex in chronic lymphocytic leukemia.
di: Catovsky, D, et al.
Pubblicazione: (2014)

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
di: Dearden, C, et al.
Pubblicazione: (2008)

Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women.
di: Catovsky, D, et al.
Pubblicazione: (2004)

Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
di: Skowronska, A, et al.
Pubblicazione: (2012)

Prognostic factors in the UK LRF CLL4 trial
di: Oscier, D, et al.
Pubblicazione: (2006)

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
di: Gonzalez, D, et al.
Pubblicazione: (2011)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
di: Dearden, C, et al.
Pubblicazione: (2011)

Prognostic factors in the UK LRF CLL4 trial.
di: Oscier, D, et al.
Pubblicazione: (2005)

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.
di: Oscier, D, et al.
Pubblicazione: (2010)

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
di: Catovsky, D, et al.
Pubblicazione: (1989)

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
di: Else, M, et al.
Pubblicazione: (2012)

LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
di: Kaderi, Mohd Arifin
Pubblicazione: (2011)

Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials
di: Geisler, C, et al.
Pubblicazione: (1999)

Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis
di: Steurer, M, et al.
Pubblicazione: (2005)

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
di: Landau, Dan A., et al.
Pubblicazione: (2014)

Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.
di: Wade, R, et al.
Pubblicazione: (2011)

Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial.
di: Wade, R, et al.
Pubblicazione: (2011)

BRCA2 gene deletion is rare in chronic lymphocytic leukemia.
di: Pilozzi, E, et al.
Pubblicazione: (1998)

Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism.
di: Kandaswamy, R, et al.
Pubblicazione: (2017)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
di: Gamm, H, et al.
Pubblicazione: (1988)

Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B.
di: Boyd, R, et al.
Pubblicazione: (2003)

CHARACTERIZATION OF BLAST CELLS IN CHRONIC GRANULOCYTIC-LEUKEMIA IN TRANSFORMATION, ACUTE MYELOFIBROSIS AND UNDIFFERENTIATED LEUKEMIA .2. STUDIES WITH MONOCLONAL-ANTIBODIES AND TERMINAL TRANSFERASE
di: Miguel, J, et al.
Pubblicazione: (1985)

The combination of fludarabine and cyclophosphamide has a beneficial effect on the incidence of hemolytic anemia in chronic lymphocytic leukemia. Results from the UK LRF CLL4 trial
di: Dearden, C, et al.
Pubblicazione: (2007)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
di: Catovsky, D, et al.
Pubblicazione: (1998)

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
di: Bosanquet, A, et al.
Pubblicazione: (2009)

Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
di: Richards, S
Pubblicazione: (1999)

PROGNOSTIC IMPORTANCE OF MYELOSUPPRESSION DURING MAINTENANCE TREATMENT OF LYMPHOBLASTIC-LEUKEMIA
di: Dolan, G, et al.
Pubblicazione: (1989)

Prognostic factors in the UK LRF CLL4 trial.
di: Oscier, D, et al.
Pubblicazione: (2006)

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
di: Clifford, R, et al.
Pubblicazione: (2012)

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
di: Dicato, M, et al.
Pubblicazione: (1991)

Detection of antigen-specific cytotoxic T lymphocytes: significance for investigative dermatology.
di: Ogg, G
Pubblicazione: (2000)

13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.
di: Parker, H, et al.
Pubblicazione: (2011)

The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: Results of a multicenter study
di: Stamatopoulos, B, et al.
Pubblicazione: (2018)

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
di: Clifford, R, et al.
Pubblicazione: (2014)

Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
di: Landau, Dan A., et al.
Pubblicazione: (2017)

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation.
di: Michallet, M, et al.
Pubblicazione: (2011)

SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
di: Wang, Lili, et al.
Pubblicazione: (2014)

Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis (Protocol)
di: Skoetz, N, et al.
Pubblicazione: (2016)

Prognostic determinants after intensified therapy of childhood lymphoblastic leukemia.
di: Vora, A, et al.
Pubblicazione: (2000)

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
di: Berndt, S, et al.
Pubblicazione: (2013)